We’re Making the Invisible Visible

Real-time image guidance during beam delivery

Discover MRIdian®

MRIdian gives clinicians the confidence to shrink margins while escalating dose and reducing fractions. Patients have more treatment options, better treatment outcomes, reduced toxicity and improved quality of life.

Learn More

Clinical Information

Combining the latest innovations in precision radiation delivery, groundbreaking MR image guidance, and on-table adaptive therapy, MRIdian represents a new paradigm in radiation oncology.

Learn More

Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay’s MRIdian Linac

ViewRay, Inc. (Nasdaq: VRAY) announced today that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian® MRI-Guided Therapy System, a cutting-edge radiation therapy device that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance. Dartmouth-Hitchcock Health is a non-profit academic health system primarily serving New Hampshire and Vermont as well as patients from across New England. As the largest health care system and employer in New Hampshire, Dartmouth-Hitchcock Health is committed to providing the highest quality of care to the nearly two million community members it serves. The addition of MRIdian brings cutting-edge MRI-guided radiation therapy closer to home for patients throughout the region and opens entirely new opportunities for research and clinical applications.

Kaohsiung Medical University Chung-Ho Memorial Hospital Begins Patient Treatments with ViewRay’s MRIdian Linac

ViewRay, Inc. announced today that Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) in Kaohsiung City, Taiwan has begun patient treatments with the MRIdian® MR-Guided Radiation Therapy System, a cutting-edge device that delivers personalized cancer care by combining the latest innovations in precision radiation delivery with ground-breaking MR-guidance. The first two patients treated at KMUH on MRIdian were provided care for prostate cancer and tumor lesions in the left lung. Both treatments took advantage of MRIdian's automated beam-gating technology, protecting surrounding organs at risk.

Boston Globe COVID-19 Article Featuring MRIdian

“Cancer doesn’t wait,” said Dr. Daniel Cagney, a radiation oncologist. “Initially in March and April, there were significant unknowns, but we’ve been living with this for a few months. ... I feel very confident that we will provide the best care for patients and it’s safe for them to come into the hospital.”

All News

 

About ViewRay

A new kind of medical technology company, ViewRay® Inc. designs, manufactures and markets MRIdian – the world’s first MRI-guided radiation therapy system to image and treat cancer patients simultaneously.

Learn More

Contact Us Today To Learn More Contact

  Global Info

CUSTOMER LOGIN

Please log in to access the ViewRay Customer Portal. To request access, please click here. Request will be reviewed within 2 business days.

Existing Users Log In
   

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy

Accept